Phibro Animal Health | PAHC - 营业费用

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.45B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	营业费用	更改		日
Align Technology	USD 864.87M		2.84M	2026-06
ANI Pharmaceuticals	USD 597.21M		34.91M	2026-06
Aurora Cannabis	CAD 48.04M		81.94M	2026-03
Bristol-Myers Squibb	USD 22.32B		2.25B	2026-06
Canopy Growth	CAD 98.72M		11.51M	2026-03
Corcept Therapeutics	USD 214.85M		343K	2026-06
Eli Lilly	USD 10.52B		496M	2026-06
Henry Schein	USD 3.26B		84M	2026-06
Idexx Laboratories	USD 791.02M		12.78M	2026-06
Knight Therapeutics	CAD 126.9M		8.29M	2025-12
Merck	USD 15.77B		2.4B	2026-06
Nektar Therapeutics	USD 49.12M		8.22M	2026-03
Pacira	USD 180.54M		7.79M	2026-06
Phibro Animal Health	USD 361.83M		29.47M	2026-03
Prestige Brands	USD 213.19M		7.06M	2026-06
Supernus Pharmaceuticals	USD 1.03B		45.58M	2026-06
Zoetis	USD 3.15B		85M	2026-06